- Home
- PMEC vs KZR Comparison
PMEC vs KZR Comparison
Compare PMEC & KZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$7.09
Company Overview
Basic Information| Metric | PMEC | KZR |
|---|---|---|
| Founded | 1984 | 2015 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.4M | 44.5M |
| IPO Year | 2021 | 2018 |
Fundamental Metrics
Financial Performance| Metric | PMEC | KZR |
|---|---|---|
| Price | $0.65 | $7.09 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | ★ 150.9K | 48.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.60 | $3.53 |
| 52 Week High | $2.44 | $7.14 |
Technical Indicators
Market Signals| Indicator | PMEC | KZR |
|---|---|---|
| Relative Strength Index (RSI) | 35.20 | 79.00 |
| Support Level | $0.60 | $6.06 |
| Resistance Level | $1.11 | N/A |
| Average True Range (ATR) | 0.12 | 0.21 |
| MACD | 0.00 | 0.06 |
| Stochastic Oscillator | 12.62 | 93.14 |
Price Performance
Historical Comparison PMEC
KZR
About PMEC Primech Holdings Ltd.
Primech Holdings Ltd is a technology-driven facilities services provider in the public and private sectors operating mainly in Singapore. The services offered by the company include Facilities services, Stewarding services, Cleaning services to offices, Cleaning services to homes, and Cleaning Supplies.
About KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.